Visit: 60 Corporate Woods, Suite 380 | Email: URVenturesInfo@urmc.rochester.edu | Phone: 585-276-6600
Are you working on a ClimateTech innovation? Venture For ClimateTech can help you validate your idea and potentially launch a viable business. Venture For ClimateTech is a non-profit global venture studio + accelerator program. They source the most promising ClimateTech innovators from around the world
Oscine Therapeutics – a biotechnology company that is developing cell-based therapies for neurological disorders based on discoveries made at the University of Rochester Medical Center (URMC) – has been acquired by Sana Biotechnology for undisclosed terms. The research behind Oscine is based on decades of work in
Oscine Corporation is a biotechnology company based on discoveries made and developed at the University of Rochester Medical Center (URMC). SEATTLE, Oct. 30, 2020 /PRNewswire/ — Sana Biotechnology, Inc. (Sana), focused on creating and delivering engineered cells as medicines, announced today the acquisition of Oscine Corp., a company
University of Rochester startup, Simulated Inanimate Models (SIM), received the Outstanding Graduate Award and $400,000 in Round 3 of the Luminate NY competition. Luminate NY, which is administered by NextCorps, is the world’s largest business accelerator for startup firms that have optics, photonics and imaging